exploratory study for children severe cardiomyopathy using YS0001

exploratory study for children severe cardiomyopathy using YS0001 - exploratory study for children severe cardiomyopathy using YS0001

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015893

Enrollment

Registered

2015-05-01

Start date

2016-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe Cardiomyopathy in Pediatric patietns

Interventions

Culture of autologous skeletal myoblasts and engineering myoblast sheets. Transplantation of myoblast sheets to heart

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Severe myopathy NYHA Class iii Ejection fraction =<35%]

Exclusion criteria

Exclusion criteria: Cardiomyopathy without other surgical options persisitent NYHA Class =>iii HF symptoms refractory to maximal medical therapy Ejection fraction =<35%

Design outcomes

Primary

Measure	Time frame
Primary endopoint is to assess the safty	—

Countries

Japan

Contacts

Public ContactMasaki Taira

Osaka University hospital Cardiovascular Surgery

taira@surg1.med.osaka-u.ac.jp06-6879-3154

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026